As of 2025-05-15, the Fair Value of Benitec Biopharma Inc (BNTC) is -4.19 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 13.58 USD, the upside of Benitec Biopharma Inc is -130.86%.
With the market price of 13.58 USD and our fair value calculation, Benitec Biopharma Inc (BNTC) is not a good investment. Investing in BNTC stocks now will result in a potential loss of 130.86%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 5Y Avg | |
| Net income | -8.27 | -13.88 | -18.21 | -19.56 | -21.75 | -16.33 |
| YoY growth | -382.25% | -67.84% | -31.20% | -7.41% | -11.20% | -99.98% |
| Market Cap (mil) | 346.97 |
| P/E | |
| Forward P/E |
| EPS | -0.84 |
| Avg earnings growth rate | -99.98% |
| TTM earnings | -21.41 |